Source: GWASCAT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
gasdermin A | 0.792 | 0.308 | 1.6E-16 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 7 | 2 | 2010 | 2019 | ||||||||
|
proteasome 26S subunit, non-ATPase 3 | 0.751 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2019 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
corneodesmosin | 0.585 | 0.731 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 7 | 4 | 2011 | 2019 | |||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 7 | 4 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2011 | 2019 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 4 | 6 | 2011 | 2019 | |||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
interferon gamma inducible protein 16 | 0.603 | 0.769 | 1.8E-11 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
epidermal growth factor receptor pathway substrate 15 like 1 | 0.743 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
spectrin alpha, erythrocytic 1 | 0.638 | 0.538 | 2.6E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
discoidin domain receptor tyrosine kinase 2 | 0.541 | 0.769 | 0.55 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
Bardet-Biedl syndrome 9 | 0.615 | 0.577 | 4.2E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2018 | ||||||||
|
serine/threonine kinase 19 | 0.691 | 0.500 | 6.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
actin related protein 2/3 complex subunit 2 | 0.769 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
cAMP responsive element binding protein 5 | 0.682 | 0.538 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2016 | 2019 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2016 | 2019 | ||||||||
|
chromodomain helicase DNA binding protein 7 | 0.441 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2019 | ||||||||
|
HBS1 like translational GTPase | 0.705 | 0.462 | 1.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||
|
V-set immunoregulatory receptor | 0.573 | 0.654 | 0.76 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2016 | 2019 |